📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Optimising the vaccine strategy of BCG, ChAdOx1 85A, and MVA85A for tuberculosis control. (2024)

First Author: Wajja A

Attributed to: Immunomodulation and Vaccines funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1016/s1473-3099(23)00758-2

PubMed Identifier: 38184003

Publication URI: http://europepmc.org/abstract/MED/38184003

Type: Journal Article/Review

Volume: 24

Parent Publication: The Lancet. Infectious diseases

Issue: 2

ISSN: 1473-3099